scispace - formally typeset
H

Hana Müllerová

Researcher at AstraZeneca

Publications -  125
Citations -  7112

Hana Müllerová is an academic researcher from AstraZeneca. The author has contributed to research in topics: COPD & Exacerbation. The author has an hindex of 31, co-authored 101 publications receiving 5883 citations. Previous affiliations of Hana Müllerová include Kurume University & GlaxoSmithKline.

Papers
More filters
Journal ArticleDOI

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study

TL;DR: Patients with increased frequency of baseline exacerbations were more likely to die from all-cause, COPD-related, and cardiovascular-related mortality in a graduated fashion, illustrating that every exacerbation counts.
Journal ArticleDOI

Inhaled corticosteroids, blood eosinophils, and FEV 1 decline in patients with COPD in a large UK primary health care setting

TL;DR: Investigating whether FEV1 decline differs between patients with and without ICS, stratified by blood EOS level found prevalent ICS use is associated with slower rates of FEV 1 decline in COPD, however, over time this association is lost.
Journal Article

Chronic obstructive pulmonary disease (COPD) burden in Japan--confronting COPD Japan survey

TL;DR: There is a need to improve COPD diagnosis and management by general practitioners through disseminating guidelines for diagnosis, management, and prevention of COPD in Japan.
Journal ArticleDOI

The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.

TL;DR: The St George's Respiratory Questionnaire appears to be relatively free of bias from demographic factors although care should be taken when making cross sectional comparisons of scores between patients in countries at different levels of socio-economic development.